Success Metrics

Active Trials
1(33%)

Phase Distribution

Ph phase_1
2
67%
Ph phase_3
1
33%

Phase Distribution

2

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
2(66.7%)
Phase 3Large-scale testing
1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Other(2)

Detailed Status

unknown2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 12 (66.7%)
Phase 31 (33.3%)

Trials by Status

active_not_recruiting133%
unknown267%

Recent Activity

1 active trials
Showing 3 of 3
active_not_recruitingphase_3

A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma.

NCT05987358
unknownphase_1

A Study of TQB3454 Tablets in Patients With Blood Tumors

NCT06218771
unknownphase_1

A Clinical Trial of TQB3454 Tablets in Healthy Adult Subjects

NCT06139367

Clinical Trials (3)

Showing 3 of 3 trials
NCT05987358Phase 3

A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma.

Active Not Recruiting
NCT06218771Phase 1

A Study of TQB3454 Tablets in Patients With Blood Tumors

Unknown
NCT06139367Phase 1

A Clinical Trial of TQB3454 Tablets in Healthy Adult Subjects

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3